Home / Compare / Retatrutide vs Semaglutide

Retatrutide vs Semaglutide

Retatrutide vs Semaglutide: how they work, doses used, FDA status and trial weight loss (28.3% vs 14.9%), with sources.

RetatrutideSemaglutide
Works onGIP + GLP-1 + glucagon (triple agonist)GLP-1 only
How it is takenInjection, once weeklyInjection weekly (Ozempic, Wegovy) or daily tablet
US statusPhase 3, not approved (filing planned early 2027)FDA-approved (2017 diabetes, 2021 weight)
Highest dose12 mg weekly (highest trial dose)2.4 mg weekly, or 7.2 mg (Wegovy HD, 2026)
Key trialTRIUMPH-1 (phase 3)STEP 1 (phase 3)
Average weight loss28.3% at 80 weeks (12 mg weekly)14.9% at 68 weeks (2.4 mg weekly)
Placebo in that trialnot stated in our source2.4%
Not a head-to-head comparison. The weight-loss numbers come from separate trials with different people, doses and lengths. A direct trial is the only way to know which works better.

How they differ

Retatrutide works on gip + glp-1 + glucagon (triple agonist); Semaglutide works on glp-1 only. Retatrutide is taken as: injection, once weekly.Semaglutide is taken as: injection weekly (ozempic, wegovy) or daily tablet.

Dose schedules and warnings: Retatrutide dosage chart ยท Semaglutide dosage chart.

Questions

Is retatrutide stronger than semaglutide?
No trial has compared them directly. In separate trials, Retatrutide averaged 28.3% weight loss (TRIUMPH-1 (phase 3), 80 weeks) and Semaglutide 14.9% (STEP 1 (phase 3), 68 weeks). Different trials enroll different people over different lengths of time, so the numbers are not a fair head-to-head comparison.
Is retatrutide FDA-approved?
Phase 3, not approved (filing planned early 2027).
Is semaglutide FDA-approved?
FDA-approved (2017 diabetes, 2021 weight).

Sources

  1. AJMC: Retatrutide achieves up to 30.3% average weight loss in phase 3 TRIUMPH-1
  2. Wilding et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). NEJM 2021

Last checked 2026-11-16. How we pick and check sources: methodology.